Načítá se...
Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases
Background: Atopic dermatitis (AD) is a chronic skin disease that affects 5-20% of children. This disease compromises the quality of life. Omalizumab offers a promising role in the treatment of severe atopic dermatitis.Objective: To share our experience with the use of omalizumab for treating severe...
Uloženo v:
| Vydáno v: | Revista Alergia México |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2019
|
| Témata: | |
| On-line přístup: | https://www.redalyc.org/articulo.oa?id=486761439003 https://www.redalyc.org/journal/4867/486761439003/ https://www.redalyc.org/journal/4867/486761439003/html/ https://www.redalyc.org/journal/4867/486761439003/486761439003.epub https://www.redalyc.org/journal/4867/486761439003/movil |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|